Literature DB >> 15652437

The syringe driver and the subcutaneous route in palliative care: the inventor, the history and the implications.

Fiona Graham1, David Clark.   

Abstract

Since the early 1980s, the syringe driver has become a commonly used technology in British palliative care, used to administer continuous subcutaneous infusions (CSCI) for symptom management. Although the device itself has not been adopted universally, it has stimulated interest in the use of CSCI in palliative care and played a significant role in the modern history of this approach. This historical case study of the syringe driver examines the life and work of its inventor, explores its development for use in childhood thalassemia, and analyzes the circumstances surrounding its adoption in palliative care. We conclude by considering the reasons for the continued popularity of the syringe driver, despite problems in its use, and reflect on the lessons which can be learned about the use of CSCI in palliative care internationally.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15652437     DOI: 10.1016/j.jpainsymman.2004.08.006

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  4 in total

1.  Normativity unbound: liminality in palliative care ethics.

Authors:  Hillel Braude
Journal:  Theor Med Bioeth       Date:  2012-04

2.  Continuous subcutaneous delivery of medications for home care palliative patients-using an infusion set or a pump?

Authors:  Sasson Menahem; Pesach Shvartzman
Journal:  Support Care Cancer       Date:  2009-09-30       Impact factor: 3.603

3.  Identification of drug combinations administered by continuous subcutaneous infusion that require analysis for compatibility and stability.

Authors:  Andrew Dickman; Matthew Bickerstaff; Richard Jackson; Jennifer Schneider; Stephen Mason; John Ellershaw
Journal:  BMC Palliat Care       Date:  2017-03-23       Impact factor: 3.234

4.  Stability evaluation of morphine, hydromorphone, metamizole and esketamine containing analgesic mixtures applied for patient-controlled analgesia in hospice and palliative care.

Authors:  Matthias Harder; Anna Fiegl-Lechner; Herbert Oberacher; Ulrike E I Horvath; Andreas Schlager; Martina Jeske; Sylvia Kerndler; Falko Schüllner; Günther K Bonn; Matthias Rainer
Journal:  Biomed Chromatogr       Date:  2022-01-26       Impact factor: 1.911

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.